Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study- Latin American Subgroup Analysis
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2986
https://www.valueinhealthjournal.com/article/S1098-3015(17)33320-X/fulltext
Title :
Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study- Latin American Subgroup Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33320-X&doi=10.1016/j.jval.2017.08.2986
First page :
A939
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2732